Prevalence of HTLV-III Infection among New Haven, Connecticut, Parenteral Drug Abusers in 1982–1983

R. D'Aquila; A. B. Williams; H. D. Kleber; A. E. Williams

doi:10.1056/NEJM198601093140211

Prevalence of HTLV-III Infection among New Haven, Connecticut, Parenteral Drug Abusers in 1982–1983

R. D'Aquila, A. B. Williams, H. D. Kleber, A. E. Williams

Medicine, Infectious Diseases Division

Research output: Contribution to journal › Letter › peer-review

17 Scopus citations

Abstract

To the Editor: The acquired immunodeficiency syndrome (AIDS) is etiologically linked to human T-cell lymphotropic virus Type III (HTLV-III). Intravenous drug use is the primary known risk factor in 17 percent of U.S. cases of AIDS.¹ We now report that the presence of HTLV-III antibody was confirmed by Western blot assay in at least 10 percent of a group of New Haven, Connecticut, parenteral drug abusers in 1982–1983. We also question the adequacy of using only enzyme-linked immunosorbent assay (ELISA) testing in this risk group. Serum specimens were collected from 283 persons presenting to the medical unit of the substance-abuse…

Original language	English (US)
Pages (from-to)	117-118
Number of pages	2
Journal	New England Journal of Medicine
Volume	314
Issue number	2
DOIs	https://doi.org/10.1056/NEJM198601093140211
State	Published - Jan 9 1986

ASJC Scopus subject areas

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1056/NEJM198601093140211

Cite this

@article{678d3dc17aae47e1adcfa9b92285402b,

title = "Prevalence of HTLV-III Infection among New Haven, Connecticut, Parenteral Drug Abusers in 1982–1983",

abstract = "To the Editor: The acquired immunodeficiency syndrome (AIDS) is etiologically linked to human T-cell lymphotropic virus Type III (HTLV-III). Intravenous drug use is the primary known risk factor in 17 percent of U.S. cases of AIDS.1 We now report that the presence of HTLV-III antibody was confirmed by Western blot assay in at least 10 percent of a group of New Haven, Connecticut, parenteral drug abusers in 1982–1983. We also question the adequacy of using only enzyme-linked immunosorbent assay (ELISA) testing in this risk group. Serum specimens were collected from 283 persons presenting to the medical unit of the substance-abuse…",

author = "R. D'Aquila and Williams, {A. B.} and Kleber, {H. D.} and Williams, {A. E.}",

year = "1986",

month = jan,

day = "9",

doi = "10.1056/NEJM198601093140211",

language = "English (US)",

volume = "314",

pages = "117--118",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "2",

}

TY - JOUR

T1 - Prevalence of HTLV-III Infection among New Haven, Connecticut, Parenteral Drug Abusers in 1982–1983

AU - D'Aquila, R.

AU - Williams, A. B.

AU - Kleber, H. D.

AU - Williams, A. E.

PY - 1986/1/9

Y1 - 1986/1/9

N2 - To the Editor: The acquired immunodeficiency syndrome (AIDS) is etiologically linked to human T-cell lymphotropic virus Type III (HTLV-III). Intravenous drug use is the primary known risk factor in 17 percent of U.S. cases of AIDS.1 We now report that the presence of HTLV-III antibody was confirmed by Western blot assay in at least 10 percent of a group of New Haven, Connecticut, parenteral drug abusers in 1982–1983. We also question the adequacy of using only enzyme-linked immunosorbent assay (ELISA) testing in this risk group. Serum specimens were collected from 283 persons presenting to the medical unit of the substance-abuse…

AB - To the Editor: The acquired immunodeficiency syndrome (AIDS) is etiologically linked to human T-cell lymphotropic virus Type III (HTLV-III). Intravenous drug use is the primary known risk factor in 17 percent of U.S. cases of AIDS.1 We now report that the presence of HTLV-III antibody was confirmed by Western blot assay in at least 10 percent of a group of New Haven, Connecticut, parenteral drug abusers in 1982–1983. We also question the adequacy of using only enzyme-linked immunosorbent assay (ELISA) testing in this risk group. Serum specimens were collected from 283 persons presenting to the medical unit of the substance-abuse…

UR - http://www.scopus.com/inward/record.url?scp=0022643763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022643763&partnerID=8YFLogxK

U2 - 10.1056/NEJM198601093140211

DO - 10.1056/NEJM198601093140211

M3 - Letter

C2 - 3941684

AN - SCOPUS:0022643763

SN - 0028-4793

VL - 314

SP - 117

EP - 118

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 2

ER -

Prevalence of HTLV-III Infection among New Haven, Connecticut, Parenteral Drug Abusers in 1982–1983

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this